Trial intelligence / Profile preview

Doxazosin for Methamphetamine Dependence

NCT02785393Phase 1Completed

Sponsor
Baylor College of Medicine
Start
Mar 2011
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Placebo Sequence with Doxazosin Sequence (2 arms). Primary endpoints: Blood Pressure and Heart Rate. Started Mar 2011; status: completed.

02

Drugs

doxazosin
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on NCT02785393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02785393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call